Healthequity Inc [HQY] stock is trading at $79.56, up 3.20%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The HQY shares have gain 3.84% over the last week, with a monthly amount glided 2.17%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Healthequity Inc [NASDAQ: HQY] stock has seen the most recent analyst activity on April 04, 2024, when JMP Securities initiated its Mkt Outperform rating and assigned the stock a price target of $101. Previously, JP Morgan reaffirmed its Overweight rating on April 02, 2024, and elevated its price target to $108. On January 03, 2024, Barclays initiated with a Overweight rating and assigned a price target of $84 on the stock. Robert W. Baird upgraded its rating to a Outperform and increased its price target to $87 on September 21, 2023. Goldman upgraded its rating to a Neutral and raised its price target to $77 on October 21, 2022. KeyBanc Capital Markets started tracking with a Overweight rating for this stock on September 16, 2022, and assigned it a price target of $85. In a note dated July 12, 2022, Goldman initiated an Sell rating and provided a target price of $59 on this stock.
Healthequity Inc [HQY] stock has fluctuated between $61.81 and $88.26 over the past year. Currently, Wall Street analysts expect the stock to reach $96.54 within the next 12 months. Healthequity Inc [NASDAQ: HQY] shares were valued at $79.56 at the most recent close of the market. An investor can expect a potential return of 21.34% based on the average HQY price forecast.
Analyzing the HQY fundamentals
Healthequity Inc [NASDAQ:HQY] reported sales of 1.04B for the trailing twelve months, which represents a growth of 17.66%. Gross Profit Margin for this corporation currently stands at 0.59% with Operating Profit Margin at 0.13%, Pretax Profit Margin comes in at 0.09%, and Net Profit Margin reading is 0.08%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.04 and Total Capital is 0.04. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.45.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 77.96 points at the first support level, and at 76.37 for the second support level. However, for the 1st resistance point, the stock is sitting at 80.40, and for the 2nd resistance point, it is at 81.25.
Ratios To Look Out For
For context, Healthequity Inc’s Current Ratio is 4.39. As well, the Quick Ratio is 4.39, while the Cash Ratio is 2.72. Considering the valuation of this stock, the price to sales ratio is 6.64, the price to book ratio is 3.30 and price to earnings (TTM) ratio is 86.60.
Transactions by insiders
Recent insider trading involved Neeleman Stephen, FOUNDER AND VICE CHAIRMAN, that happened on Jul 25 ’24 when 35000.0 shares were sold. Director, Wellborn Gayle Furgurson completed a deal on Jul 09 ’24 to sell 5297.0 shares. Meanwhile, Former Director Corvino Frank sold 7705.0 shares on Jul 08 ’24.
